RedHill Biopharma Ltd.: RedHill gives up migraine product (RHB-103). Upside remains, but the price target is decreased to NIS 2.27.

• Post author:jaimeuss_admin
• Post published:17 בSeptember 2018
• Post category:Research

Continue ReadingRedHill Biopharma Ltd.: RedHill gives up migraine product (RHB-103). Upside remains, but the price target is decreased to NIS 2.27.